SVNNF yields 1666.67% · MRK yields 2.76%● Live data
📍 SVNNF pulled ahead of the other in Year 1
Combined, SVNNF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SVNNF + MRK for your $10,000?
Savannah Energy PLC engages in the exploration, development, and production of natural gas and crude oil. It holds license interest in Agadem Rift Basin prospective located in the south east Niger covering an area of approximately 13,655 square kilometers. The company also has an 80% interest in the Uquo field asset; 51% interest in the Stubb Creek oil and gas field; and 80% interest in the Accugas midstream assets located in south east Nigeria. In addition, it is involved in the development of other energy related projects in Africa. The company was formerly known as Savannah Petroleum Plc and changed its name to Savannah Energy PLC in April 2020. Savannah Energy PLC was incorporated in 2014 and is headquartered in London, the United Kingdom.
Full SVNNF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.